Cell therapies for lung disease

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

Abstract

The World Health Organization (WHO) predicts that chronic lung disease will become the third leading cause of mortality worldwide by the year 2030. While most of this burden rests on the shoulders of resource-poor countries having arisen from environmental pollution and smoking, the burden of disease in resource-rich nations will not be insignificant. Chronic lung diseases cost USD 154 billion in health care within the United States alone (National Heart, Lung, and Blood Institute 2005). This chapter will focus on the most common lung diseases in neonates, children, and adults and cell therapies directed at these diseases.
Original languageEnglish
Title of host publicationGene and Cell Therapy
Subtitle of host publicationTherapeutic Mechanisms and Strategies
EditorsNancy Smyth Templeton
Place of PublicationBoca Raton FL USA
PublisherCRC Press
Pages1157-1169
Number of pages13
Edition4th
ISBN (Print)9781466571990
Publication statusPublished - 2015

Cite this

Lim, R., Tan, J. L., & Wallace, E. M. (2015). Cell therapies for lung disease. In N. S. Templeton (Ed.), Gene and Cell Therapy: Therapeutic Mechanisms and Strategies (4th ed., pp. 1157-1169). Boca Raton FL USA: CRC Press.